Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis

Sienna S. Drake,Aliyah Zaman,Christine Gianfelice,Elizabeth M.-L. Hua,Kali Heale,Elia Afanasiev,Wendy Klement,Jo Anne Stratton,Alexandre Prat,Stephanie Zandee,Alyson E. Fournier
DOI: https://doi.org/10.1186/s12974-024-03278-2
IF: 9.3
2024-11-03
Journal of Neuroinflammation
Abstract:The role of senescence in disease contexts is complex, however there is considerable evidence that depletion of senescent cells improves outcomes in a variety of contexts particularly related to aging, cognition, and neurodegeneration. Much research has shown previously that inflammation can promote cellular senescence. Microglia are a central nervous system innate immune cell that undergo senescence with aging and during neurodegeneration. The contribution of senescent microglia to multiple sclerosis, an inflammatory neurodegenerative disease, is not clear, but microglia are strongly implicated in chronic active lesion pathology, tissue injury, and disease progression. Drugs that could specifically eliminate dysregulated microglia in multiple sclerosis are therefore of great interest to the field.
immunology,neurosciences
What problem does this paper attempt to address?